Target intelligence / Profile preview

Sal-like protein 2 pseudogene (No standard abbreviation; "SAL-like 2, pseudogene" is used, but common abbreviations are not established for pseudogenes.)

Target
No standard abbreviation; "SAL-like 2, pseudogene" is used, but common abbreviations are not established for pseudogenes.
Molecular classification
Pseudogene, Processed pseudogene, Non-coding RNA pseudogene
01

Overview

Sal-like protein 2 pseudogene (ENSG00000267187) is a DNA sequence in the human genome with significant similarity to the gene encoding Sal-like protein 2, a zinc finger transcription factor. Unlike its functional parent gene, pseudogenes of this type are characterized by disruptive mutations (e.g., frameshifts, premature stop codons), lack introns (if processed), and do not produce functional proteins. Pseudogenes may arise through gene duplication or retrotransposition followed by disabling mutations[2][1][4][5]. While some pseudogenes are transcribed and may participate in gene regulatory networks, there is no evidence that Sal-like 2 pseudogene has any biological function or disease association. These sequences are mainly relevant for genome annotation and may affect the accuracy of genetic variant analysis and diagnostics due to their sequence similarity with parent genes[7].

Other names
SALL2 pseudogeneSAL-like 2 pseudogeneSal-like 2 pseudogeneSAL-like 2, pseudogene
02

Mechanism of action

None applicable, as drugs do not target this pseudogene.

03

Biological functions

None demonstrated for this specific pseudogene.Pseudogenes in general may regulate their parent genes or have roles as non-coding RNAs in rare cases, but there is no evidence for Sal-like 2 pseudogene function.
04

Disease associations

None established for Sal-like 2 pseudogene.Some pseudogenes are implicated in regulatory networks affecting disease, but no evidence exists for this locus.
05

Safety considerations

None specific, though the presence of pseudogenes can complicate molecular diagnostics by confusing genetic analyses with their highly homologous parent genes[7]
06

Interacting drugs

None
07

Biomarkers

None known or used clinically

Beyond the preview

Go deeper on Sal-like protein 2 pseudogene (No standard abbreviation; "SAL-like 2, pseudogene" is used, but common abbreviations are not established for pseudogenes.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sal-like protein 2 pseudogene (No standard abbreviation; "SAL-like 2, pseudogene" is used, but common abbreviations are not established for pseudogenes.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call